- Investing Ideas
- Swedish Pharmaceuticals & Biotech High Insider Buying
Swedish Pharmaceuticals & Biotech High Insider Buying
Results
12
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
12 companies
Swedish Orphan Biovitrum
Market Cap: SEK 138.3b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 400.20
7D
-4.9%
1Y
44.2%
Camurus
Market Cap: SEK 32.1b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 537.00
7D
-7.3%
1Y
-8.8%
AddLife
Market Cap: SEK 19.3b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 158.60
7D
-5.0%
1Y
-3.6%
MedCap
Market Cap: SEK 7.3b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.
MCAP
SEK 489.00
7D
-5.2%
1Y
17.7%
Swedencare
Market Cap: SEK 4.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 26.85
7D
-5.5%
1Y
-24.9%
Devyser Diagnostics
Market Cap: SEK 1.5b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 89.50
7D
4.2%
1Y
-8.4%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.94
7D
-0.8%
1Y
-14.8%
Corline Biomedical
Market Cap: SEK 411.1m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 16.05
7D
-2.7%
1Y
72.6%
Mendus
Market Cap: SEK 300.6m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 4.90
7D
-2.6%
1Y
-1.5%
Promimic
Market Cap: SEK 204.0m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 10.80
7D
2.9%
1Y
-58.9%
Alzinova
Market Cap: SEK 70.4m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.45
7D
-22.1%
1Y
-75.9%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%